HyperSight Imaging for Cancer

N/A

Recruiting

Research Sponsored by Varian, a Siemens Healthineers Company

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patient age is ≥ 18 years old

Patient has a diagnosis of primary or metastatic cancer, including but not limited to tumors arising from or involving the head/neck, lungs, liver, pancreas, prostate, urinary bladder, rectum, cervix or uterus

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 1 of radiation treatment, day 2 of radiation treatment, and the last day of radiation treatment (up to 6 weeks after the start of treatment).

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to study a new imaging technology called HyperSight used on cancer patients during radiation treatment. The goal is to assess the quality of the images produced and how easy it is to use the

Who is the study for?

This trial is for individuals with lung, abdominal, head and neck, or pelvic cancers who are undergoing radiation treatment. Participants must be able to receive imaging on a specific machine (TrueBeam). The exact eligibility criteria aren't provided here.

What is being tested?

The study is testing the image quality of HyperSight Imaging technology when used during radiation therapy sessions on a TrueBeam linear accelerator. It's a single-group study focusing on how well this new imaging tech works in practice.

What are the potential side effects?

Since this trial focuses on evaluating imaging technology rather than medication or invasive procedures, side effects are not the main concern. However, typical risks associated with additional exposure to diagnostic imaging may apply.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

My cancer originates from or affects areas like the head, neck, lungs, liver, and others.

Select...

I was chosen to undergo radiation therapy with a Varian TrueBeam system.

Select...

I was prescribed a specific radiation treatment plan of at least 20 Gy over 5 days.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 1 of radiation treatment, day 2 of radiation treatment, and the last day of radiation treatment (up to 6 weeks after the start of treatment).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 1 of radiation treatment, day 2 of radiation treatment, and the last day of radiation treatment (up to 6 weeks after the start of treatment).

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 of radiation treatment, day 2 of radiation treatment, and the last day of radiation treatment (up to 6 weeks after the start of treatment). for reporting.